Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s disease
Open Access
- 24 January 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1501319
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) or liver fibrosis may share similar pathophysiological features with Parkinson’s disease (PD), yet their correlation was unclear. This study aimed to explore their correlation between PD and liver fibrosis using the fibrosis-4 score (FIB-4) as a surrogate marker.Methods: We analyzed Parkinson’s Progression Markers Initiative (PPMI) data and enrolled PD patients with comprehensive baseline and 5-year follow-up time-point clinical data. Participants were categorized based on FIB-4 levels to assess the association between FIB-4 scores and various clinical scales, controlling for potential confounders. Differences in the progression of clinical scales over five years were compared using generalized linear mixed models (GLMM).Results: Baseline FIB-4 levels positively correlated to scores of baseline section III of the Unified-Parkinson Disease Rating Scale (UPDRS III) (r = 0.145, p = 0.017), Epworth Sleepiness Scale (EPSS) (r = 0.140, P = 0.022), Hopkins Verbal Learning Test (HVLT)-delayed recall (r = 0.128, P = 0.036) and HVLT-retention (r = 0.128, p = 0.036). GLMM analysis revealed an independent correlation between FIB-4 subgroup*time and several clinical scales including the State-trait Anxiety Inventory (STAI), Symbol Digit Modalities Test (SDMT), Semantic Fluency Test (SF), HVLT-total recall, and HVLT-delayed recall, with the high FIB-4 subgroup exhibiting a greater decline in these scores compared to the low FIB-4 subgroup (all p<0.05).Conclusion: Elevated baseline FIB-4 correlated to more severe baseline daytime sleepiness, motor symptoms, and memory function in PD patients, along with a more rapid decline in cognitive functions such as executive function, information processing ability, and memory. Additionally, a high FIB-4 might confer a protective effect against anxiety.Keywords
This publication has 42 references indexed in Scilit:
- GBA moderates cognitive reserve's effect on cognitive function in patients with Parkinson's diseaseJournal of Neurology, 2024
- Gut-liver axis: Pathophysiological concepts and clinical implicationsCell Metabolism, 2022
- Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank studyAlzheimer's & Dementia, 2022
- The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary CareJournal of General Internal Medicine, 2022
- Social role functioning in Parkinson's disease: A mixed‐methods systematic reviewInternational Journal of Geriatric Psychiatry, 2019
- Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s DiseaseAgeing Research Reviews, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesClinical Liver Disease, 2018
- Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham StudyJAMA Neurology, 2018
- Liver fibrosis scores predict liver disease mortality in the United States populationHepatology, 2017
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006